![1H-Indole-2-carbonitrile, 4-methyl-5-[[4-[[2-(methylamino)-6-(2,2,2-trifluoroethyl)thieno[2,3-d]pyrimidin-4-yl]amino]-1-piperidinyl]methyl]-1-[(2S)-2-[4-(methylsulfonyl)-1-piperazinyl]propyl]- structure, CAS 2134675-36-6](/structures/210000/193686_1_2134675_36_6.png)
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 2134675-36-6 |
| Catalog No. | 2A-1192162 |
| Chinese Name | Ziftomenib |
| Molecular Formula | C33H42O2N9S2F3 |
| Molecular Weight | 717.88 |
| Application | Ziftomenib is a menin-MLL interaction inhibitor (WO2017161028A1, compound 151) with anti-tumor activity [1]. |
| PubChem ID | 384713528 |
| MDL Number | MFCD34574446 |
| InChI | InChI=1S/C33H42F3N9O2S2/c1-21(43-11-13-44(14-12-43)49(4,46)47)19-45-25(18-37)15-27-22(2)23(5-6-29(27)45)20-42-9-7-24(8-10-42)39-30-28-16-26(17-33(34,35)36)48-31(28)41-32(38-3)40-30/h5-6,15-16,21,24H,7-14,17,19-20H2,1-4H3,(H2,38,39,40,41)/t21-/m0/s1 |
| InChI Key | BGGALFIXXQOTPY-NRFANRHFSA-N |
| Transport Info | Product Name: Ziftomenib |
| Related Products in Pharmaceutical Intermediates | ||
|---|---|---|
| (S)-2-(1-Aminoethyl)-4-fluorophenol hydrochloride | 2379311-62-1 | 2A-1192112 |
| (R)-6-methylpiperidin-2-one | 68330-73-4 | 2A-1192114 |
| (S)-3-Amino-piperidine-2,6-dione hydrochloride | 25181-50-4 | 2A-1192123 |
| 1,2-Piperidinedicarboxylic acid, 5-hydroxy-, 1-(1,1-diMethylethyl) ester, (2S,5S)- | 1487347-86-3 | 2A-1192125 |
| (R)-3-(ACETYLTHIO)-2-METHYLPROPIONYL CHLORIDE | 74345-73-6 | 2A-1192126 |
| (S)-2-butylamine Hydrochloride | 31519-50-3 | 2A-1192180 |
| (1R,2R)-(-)-2-Benzyloxycyclopentylamine | 181657-56-7 | 2A-1192318 |
| N-BOC-2-IODOANILINE | 161117-84-6 | 2A-1192330 |
| 1-Aminobicyclo[2.2.2]octane | 1193-42-6 | 2A-1192351 |
| 5H-Pyrrolo[2,3-d]pyrimidine-5-acetic acid, 2-amino-4-chloro-6,7-dihydro-, methyl ester | 1251761-84-8 | 2A-1192357 |
| Browse all Pharmaceutical Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA